NYSE$NVST
Envista Holdings Corporation · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
Reported a solid quarter with core sales growth and progress in transforming the portfolio through acquisitions.
Envista Holdings Corporation announced Q2 2022 results with sales increasing 1.3% to $645.8 million and core sales growth of 4.0%. Net income was $44.5 million, or $0.25 per diluted share, while adjusted net income was $86.0 million, or $0.48 per diluted share. The company closed acquisitions of Carestream Dental’s Intraoral Scanner Business and Osteogenics' Regenerative Solutions business.
- Delivered core sales growth of 4% and adjusted EBITDA margins of 19.7%.
- Navigated challenging operating environment with supply chain disruptions and inflation.
- Closed acquisitions of Carestream Dental’s Intraoral Scanner Business and Osteogenics' Regenerative Solutions business.
- Updated 2022 guidance to mid-single digits core sales growth, committed to 20% adjusted EBITDA margin.
Headline financials
Revenue & EPS history
Envista · Revenue · Quarterly
$646M
Revenue by segment
Envista · $646M total across 2 segments · Q2 2022
- Specialty Products & Technologies$408M+5.6%63.1%
- Equipment & Consumables$238M-32.7%36.9%
Forward guidance
Given the persistent inflationary pressures, continued supply chain disruptions, and an uncertain geopolitical environment, Envista is updating its guidance for 2022 and now expects core sales to grow mid-single digits for 2022. They remain committed to delivering an adjusted EBITDA margin of 20% for the full year.
Headwinds
- Persistent inflationary pressures
- Continued supply chain disruptions
- Uncertain geopolitical environment
- Additional downside risk for demand in the second half of 2022
- Certain information is not available and cannot be reasonably estimated on a GAAP basis
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2022
-0.1%
Avg return
Earnings day
+1.6%
Avg return
5 days after
-0.8%
Avg return
30 days after
48%
16 / 33 earnings
Positive
+17.8%
Q4 2025
Best reaction
-9.7%
Q1 2020
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +1.5% | -10.3% | -14.7% | |
| Q4 2025 | +17.8% | +22.5% | +8.7% | |
| Q3 2025 | -0.2% | +0.0% | +3.8% | |
| Q1 2025 | +3.8% | +3.1% | +11.8% | |
| Q4 2024 | +5.9% | +2.2% | -10.4% | |
| Q3 2024 | +11.6% | +13.3% | +18.6% | |
| Q2 2024 | +4.7% | +2.9% | +10.7% | |
| Q1 2024 | +0.7% | -3.2% | -1.6% | |
| Q4 2023 | -8.5% | -7.0% | -13.4% | |
| Q3 2023 | -8.7% | -8.3% | +2.7% | |
| Q2 2023 | +0.8% | +2.8% | -4.8% | |
| Q1 2023 | -6.4% | -7.1% | -12.0% | |
| Q4 2022 | -3.0% | -3.5% | -9.8% | |
| Q3 2022 | +2.8% | +3.4% | +4.0% | |
| Q2 2022 | +1.3% | +1.4% | -11.3% | |
| Q1 2022 | +7.5% | +5.4% | +6.2% | |
| Q4 2021 | +8.7% | +8.0% | +3.9% | |
| Q3 2021 | +5.4% | +6.1% | -3.9% | |
| Q2 2021 | -7.5% | -6.1% | +0.3% | |
| Q1 2021 | +2.1% | +3.1% | -4.1% | |
| Q4 2020 | +2.2% | +3.6% | +4.7% | |
| Q3 2020 | +7.8% | +9.9% | +20.4% | |
| Q2 2020 | -3.8% | +0.4% | +5.2% | |
| Q1 2019 | -9.7% | -8.9% | +10.7% | |
| Q1 2020 | -9.7% | -8.9% | +10.7% | |
| Q4 2019 | -6.5% | -8.1% | -19.8% | |
| Q4 2018 | -3.2% | +5.3% | -5.9% | |
| Q4 2017 | -3.2% | +5.3% | -5.9% | |
| Q3 2018 | -3.2% | +5.3% | -5.9% | |
| Q3 2019 | -3.2% | +5.3% | -5.9% | |
| Q2 2019 | -3.2% | +5.3% | -5.9% | |
| Q2 2018 | -3.2% | +5.3% | -5.9% | |
| Q1 2018 | -3.2% | +5.3% | -5.9% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro